Arcticzymes Technologies ASA
OSE:AZT

Watchlist Manager
Arcticzymes Technologies ASA Logo
Arcticzymes Technologies ASA
OSE:AZT
Watchlist
Price: 13.16 NOK -2.52%
Market Cap: 684.8m NOK
Have any thoughts about
Arcticzymes Technologies ASA?
Write Note

Arcticzymes Technologies ASA
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arcticzymes Technologies ASA
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Arcticzymes Technologies ASA
OSE:AZT
Income from Continuing Operations
kr7m
CAGR 3-Years
-53%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Income from Continuing Operations
-kr133.5m
CAGR 3-Years
-4%
CAGR 5-Years
-11%
CAGR 10-Years
-12%
B
Bergenbio ASA
OSE:BGBIO
Income from Continuing Operations
-kr152.3m
CAGR 3-Years
21%
CAGR 5-Years
5%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Income from Continuing Operations
-kr87.9m
CAGR 3-Years
-28%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
N
Nykode Therapeutics ASA
OSE:NYKD
Income from Continuing Operations
-$37.9m
CAGR 3-Years
N/A
CAGR 5-Years
-50%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Income from Continuing Operations
-kr18.7m
CAGR 3-Years
64%
CAGR 5-Years
45%
CAGR 10-Years
7%
No Stocks Found

Arcticzymes Technologies ASA
Glance View

Market Cap
672.1m NOK
Industry
Biotechnology

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. The company is headquartered in Tromso, Troms. The company went IPO on 2005-11-04. The firm focuses on new solutions within molecular research, in vitro diagnostics and therapeutics. Arcticzymes Technologies ASA invests in BetaGlucans, which develops immunomodulating beta-glucan products, serving several different market segments including wound care, animal and consumer health and adjuvants.

AZT Intrinsic Value
21.99 NOK
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Arcticzymes Technologies ASA's Income from Continuing Operations?
Income from Continuing Operations
7m NOK

Based on the financial report for Sep 30, 2024, Arcticzymes Technologies ASA's Income from Continuing Operations amounts to 7m NOK.

What is Arcticzymes Technologies ASA's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-53%

Over the last year, the Income from Continuing Operations growth was -60%. The average annual Income from Continuing Operations growth rates for Arcticzymes Technologies ASA have been -53% over the past three years .

Back to Top